RUA Life Sciences is a holding company for a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-EonTM).

16 Jul 2021

RUA Life Sciences - FY Results - Investor Presentation video - 16 July 2021

The senior management team at RUA Life Sciences talk us through their latest set of numbers, their frustrations over a wayward bit of cellulose which they are 99% confident came from an 'overvigorous cleaning process', and their confidence around their timeline for the 510k submission for the vascular graft. They also cover the successful integration of RUA Medical, its growing capacity, and the opportunities for the Elast-Eon™ Heart Valve.

Return to RUA Life Sciences

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 3rd Floor, 80 Cheapside, London, EC2V 6EE

Website design & development by Breckenridge